4.6 Editorial Material

Nanotechnology for drug delivery: the perfect partnership

Journal

EXPERT OPINION ON DRUG DELIVERY
Volume 5, Issue 9, Pages 927-929

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1517/17425247.5.9.927

Keywords

liposome; nanoparticle; nanotechnology

Funding

  1. NCI NIH HHS [CA119349] Funding Source: Medline
  2. NIBIB NIH HHS [EB003647] Funding Source: Medline

Ask authors/readers for more resources

The pipelines of pharmaceutical companies are in many cases believed to be drying up and many blockbuster drugs are expected to be coming off patent in the near term. The application of nanotechnology to drug delivery is widely expected to create novel therapeutics capable of changing the landscape for pharmaceutical and biotechnology industries. This editorial highlights the nanotechnology platforms that are under development or in clinical use today, and points to exciting areas of opportunity where nanotechnology may enable the development of more effective and safer targeted therapeutics for a myriad of clinical applications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available